LSP takes part in Euronext Amsterdam gong ceremony



BioCapital Europe, an LSP healthcare conference, will take place for the 15th time in Amsterdam. Geraldine O’Keeffe, Partner at LSP and conference host, sounds the gong in recognition of the 15th anniversary of the event.
 
BioCapital Europe is one of Europe’s premier life sciences investment conference, offering venture capitalists and institutional investors unique and timely access to approximately 40 biotech companies at an exciting stage in their development. The presenting companies for this years’ event are developing cutting edge, innovative healthcare solutions to a variety of diseases such as novel treatments for cancer, ground breaking medical devices for stroke and heart disease, in additional to breakthrough diagnostics and therapies for a wide range of diseases.
 
LSP is a leading independent European investment firm, providing financing for private and public life-science companies. Since the late 1980s, LSP’s management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. With over EUR 1 billion of investment capital raised to date and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s largest and most experienced specialist life-science investors.

Click here to see the video of the gong ceremony.
« back to overview

LSP takes part in Euronext Amsterdam gong ceremony



BioCapital Europe, an LSP healthcare conference, will take place for the 15th time in Amsterdam. Geraldine O’Keeffe, Partner at LSP and conference host, sounds the gong in recognition of the 15th anniversary of the event.
 
BioCapital Europe is one of Europe’s premier life sciences investment conference, offering venture capitalists and institutional investors unique and timely access to approximately 40 biotech companies at an exciting stage in their development. The presenting companies for this years’ event are developing cutting edge, innovative healthcare solutions to a variety of diseases such as novel treatments for cancer, ground breaking medical devices for stroke and heart disease, in additional to breakthrough diagnostics and therapies for a wide range of diseases.
 
LSP is a leading independent European investment firm, providing financing for private and public life-science companies. Since the late 1980s, LSP’s management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. With over EUR 1 billion of investment capital raised to date and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s largest and most experienced specialist life-science investors.

Click here to see the video of the gong ceremony.
« back to overview